Moreover, in diabetic cohorts, Zhang et al. [60] identified chemerin as an independent risk factor for NAFLD, with levels increasing in parallel with steatosis severity and closely associated with obesity, dyslipidemia, and HOMA-IR. Here, RARRES2 is linked to metabolic dysfunction-associated steatotic liver disease.